tiprankstipranks
Trending News
More News >
Scopus BioPharma (SCPS)
OTHER OTC:SCPS
US Market

Scopus BioPharma (SCPS) Financial Statements

Compare
67 Followers

Scopus BioPharma Financial Overview

Scopus BioPharma's market cap is currently $12.63K. The company's EPS TTM is $; its P/E ratio is ―; Scopus BioPharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -11.71M$ -27.63M$ -10.16M$ -2.69M$ -685.96K
EBITDA$ -11.71M$ -27.63M$ -10.15M$ -2.69M$ -685.96K
Net Income$ -11.61M$ -27.73M$ -11.57M$ -2.69M$ -685.96K
Balance Sheet
Cash & Short-Term Investments$ 124.58K$ 7.94M$ 1.83M$ 36.75K$ 1.66K
Total Assets$ 392.26K$ 8.19M$ 1.97M$ 771.68K$ 132.64K
Total Debt$ 0.00$ 0.00$ 2.28M$ 0.00$ 0.00
Net Debt$ -124.58K$ -7.94M$ 451.63K$ -36.75K$ -1.66K
Total Liabilities$ 7.45M$ 4.17M$ 3.81M$ 854.54K$ 137.96K
Stockholders' Equity$ -6.56M$ 4.02M$ -1.83M$ -82.86K$ -5.33K
Cash Flow
Free Cash Flow$ -8.13M$ -11.43M$ -2.53M$ -2.12M$ -747.32K
Operating Cash Flow$ -8.13M$ -11.42M$ -2.53M$ -2.12M$ -747.32K
Investing Cash Flow$ -1.55K$ -2.00K$ 0.00$ -4.25K$ 0.00
Financing Cash Flow$ 241.94K$ 17.56M$ 4.35M$ 2.18M$ 597.63K
Currency in USD

Scopus BioPharma Earnings and Revenue History

Scopus BioPharma Debt to Assets

Scopus BioPharma Cash Flow

Scopus BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis